---
category: news
title: "One Key to Pandemic Retailing: Artificial Intelligence"
excerpt: "Retail is no stranger to artificial intelligence. Nearly a decade ago ... Gilead Sciences won approval for remdesivir as an anti-Covid therapy. With the election looming, House Speaker Nancy Pelosi set a Tuesday deadline to reach a deal on Covid relief."
publishedDateTime: 2020-10-24T04:07:00Z
originalUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
webUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
ampWebUrl: "https://www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
cdnAmpWebUrl: "https://www-barrons-com.cdn.ampproject.org/c/s/www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
type: article

provider:
  name: Barron's
  domain: barrons.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://images.barrons.com/im-248999/social"
    width: 1280
    height: 640
    isCached: true

secured: "KVwhhySdFIftvs02JG/uEWWl1E3pVu82vPbT54ZgTWwUPfu0uqZ7r3v12aSgG+NfoluppcFuMdvs0pNl5GqEQIpp4vCbsMZlDVDJQr/5U/0WcN9oidPMiZ8QXj72eF+ahhQHZK3Y9QB84KxSNH4w1IyqfrnFJFzcuncBhOBHOgd3kkROSm/Uu0PVPxrSicFdhjwDurCszDhzpfQRlan/wB0LRBh7CpgX9gcyYiAT5+yrYXA9L+nYpRXJrVvSFdJ7lMdTTieG4z16hZmfRxxlQBSuzuFB5lBVCPNDWKp+jP4ntCk9XkebvwUtuvt6YqzxhGynGuib5irQqBcHyEIrFNeSdGNXkrJBQBlEcvGmVQU=;SNO34mzYF9whmnVUMCT+fg=="
---

